Our Insights
Our insights
As access experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the latest expanded access activity and insights.
The real value of mapping the Expanded Access Program (EAP) ecosystem
Optimizing commercial launch for orphan drugs with Expanded Access Programs
New partnership announcement
Global Early Access Program for new medicine
The Expanded Access Program (EAP) playbook
Uniphar to run pan-European Managed Access Program for new epilepsy drug
COVID-19 is no obstacle to Expanded Access
Marinus Pharmaceuticals initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV
TFF Pharmaceuticals and Uniphar announce EAP for voriconazole inhalation powder
SIFI and Uniphar announce the opening of an Early Access Program for Akantior
